Insider Trading disclosures for Immunogen, Inc.

The latest disclosure was made by Theresa Wingrove in Immunogen, Inc. where a trade of 187,667 Common Stock done at an average price of $29.6 was reported to US exchanges on Jan. 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Sale of securities on an exchange or to another person at price $ 29.64 per share.	16 Jan 2024	187,667	3,426 (0%)	0%	29.6	5,562,450	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	126,100	0	-		-	Stock Option (Right to Buy)
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.75 per share.	16 Jan 2024	2,667	64,993 (0%)	0%	5.7	15,335	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.83 per share.	16 Jan 2024	58,900	62,326 (0%)	0%	4.8	284,487	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	2,667	1,333	-		-	Stock Option (right to buy)
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.25 per share.	16 Jan 2024	126,100	191,093 (0%)	0%	5.3	662,025	Common Stock
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jan 2024	58,900	0	-		-	Stock Option (right to buy)
J. Michael Vasconcelles	EVP R&D & MEDICAL AFFAIRS	Grant, award, or other acquisition of securities at price $ 16.01 per share.	29 Dec 2023	1,327	1,327 (0%)	0%	16.0	21,245	Common Stock
Alan Goldberg Mark	Director	Grant, award, or other acquisition of securities at price $ 29.65 per share.	29 Dec 2023	569	60,720 (0%)	0%	29.7	16,871	Common Stock
M. Thackray Helen	Director	Grant, award, or other acquisition of securities at price $ 29.65 per share.	29 Dec 2023	252	3,074 (0%)	0%	29.7	7,472	Common Stock
Stacy Coen Ann	SVP & CHIEF BUSINESS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Dec 2023	30,000	303,465	-		-	Stock Option (Right to Buy)
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share.	29 Dec 2023	30,000	63,140 (0%)	0%	5.3	159,600	Common Stock
Stuart Arbuckle A.	Director	Grant, award, or other acquisition of securities at price $ 29.65 per share.	29 Dec 2023	442	5,381 (0%)	0%	29.6	13,105	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 16.01 per share.	29 Dec 2023	615	3,426 (0%)	0%	16.0	9,846	Common Stock
Lentini Renee	VP & PRIN ACCTG OFFICER	Grant, award, or other acquisition of securities at price $ 16.01 per share.	29 Dec 2023	467	8,919 (0%)	0%	16.0	7,477	Common Stock
Coen Ann Stacy	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 16.01 per share.	29 Dec 2023	367	63,507 (0%)	0%	16.0	5,876	Common Stock
Renee Lentini	VP & PRIN ACCTG OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Dec 2023	15,000	15,000 (0%)	0%		0	Common Stock
Renee Lentini	VP & PRIN ACCTG OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Dec 2023	15,000	22,500	-		-	Restricted Stock Unit
Lentini Renee	VP & PRIN ACCTG OFFICER	Sale of securities on an exchange or to another person at price $ 29.74 per share.	22 Dec 2023	6,548	8,452 (0%)	0%	29.7	194,738	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2023	89,657	115,273	-		-	Stock Option (right to buy)
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share.	15 Dec 2023	89,657	120,256 (0%)	0%	5.3	476,975	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Sale of securities on an exchange or to another person at price $ 29.40 per share.	15 Dec 2023	117,445	2,811 (0%)	0%	29.4	3,452,883	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share.	15 Dec 2023	27,788	30,599 (0%)	0%	4.5	126,435	Common Stock
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2023	27,788	35,871	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Nov 2023	10,000	0	-		-	Stock Option (Right to Buy)
Peterson Kristine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.07 per share.	30 Nov 2023	10,000	20,000 (0%)	0%	13.1	130,700	Common Stock
Kristine Peterson	Director	Sale of securities on an exchange or to another person at price $ 28.90 per share.	30 Nov 2023	20,000	0 (0%)	0%	28.9	578,000	Common Stock
Peterson Kristine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Nov 2023	10,000	0	-		-	Stock Option (right to buy)
Coen Ann Stacy	SVP & CHIEF BUSINESS OFFICER	Sale of securities on an exchange or to another person at price $ 29.20 per share.	30 Nov 2023	3,826	33,140 (0%)	0%	29.2	111,719	Common Stock
Peterson Kristine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.10 per share.	30 Nov 2023	10,000	10,000 (0%)	0%	10.1	101,000	Common Stock
Jonathan Mitchell Dean	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share.	22 Sep 2023	10,000	103,000 (0%)	0%	14.7	147,000	Common Stock
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 18.87 per share.	30 Jun 2023	894	59,088 (0%)	0%	18.9	16,870	Common Stock
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 4.05 per share.	30 Jun 2023	2,811	86,156 (0%)	0%	4.1	11,385	Common Stock
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 18.87 per share.	30 Jun 2023	695	4,112 (0%)	0%	18.9	13,115	Common Stock
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 4.05 per share.	30 Jun 2023	5,241	441,449 (0%)	0%	4.0	21,226	Common Stock
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 18.87 per share.	30 Jun 2023	397	2,350 (0%)	0%	18.9	7,491	Common Stock
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 4.05 per share.	30 Jun 2023	3,264	113,935 (0%)	0%	4.0	13,219	Common Stock
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 4.05 per share.	30 Jun 2023	3,792	10,960 (0%)	0%	4.1	15,358	Common Stock
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 4.05 per share.	30 Jun 2023	3,195	22,843 (0%)	0%	4.1	12,940	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Tracey L. McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	19,597	19,597	-		-	Stock Option (right to buy)
Tracey L. McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	13,090	13,090	-		-	Restricted Stock Unit
Isabel Kalofonos	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	47,375	47,375	-		-	Restricted Stock Unit
Isabel Kalofonos	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	284,250	284,250	-		-	Stock Option (Right to Buy)
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 3.84 per share.	31 Mar 2023	4,394	58,194 (0%)	0%	3.8	16,873	Common Stock
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 3.84 per share.	31 Mar 2023	3,417	3,417 (0%)	0%	3.8	13,121	Common Stock
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 3.84 per share.	31 Mar 2023	1,953	1,953 (0%)	0%	3.8	7,500	Common Stock
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	54,600	54,600	-		-	Restricted Stock Unit
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	23,400	23,400	-		-	Restricted Stock Unit
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	140,400	140,400	-		-	Stock Option (right to buy)
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	153,700	153,700	-		-	Restricted Stock Unit
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	922,400	922,400	-		-	Stock Option (right to buy)
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	256,300	256,300	-		-	Stock Option (right to buy)
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	42,700	42,700	-		-	Restricted Stock Unit
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	63,400	63,400	-		-	Restricted Stock Unit
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	41,000	41,000	-		-	Restricted Stock Unit
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	245,900	245,900	-		-	Stock Option (right to buy)
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	25,305	25,305	-		-	Restricted Stock Unit
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2023	50,610	50,610	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Dec 2022	3,024	142,667	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Dec 2022	3,402	160,350	-		-	Deferred Share Unit
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 3.92 per share.	30 Dec 2022	1,131	83,345 (0%)	0%	3.9	4,434	Common Stock
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Dec 2022	2,772	50,303	-		-	Deferred Share Unit
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 3.92 per share.	30 Dec 2022	436	110,671 (0%)	0%	3.9	1,709	Common Stock
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 3.92 per share.	30 Dec 2022	1,351	19,648 (0%)	0%	3.9	5,296	Common Stock
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Dec 2022	37,500	37,500	-		-	Restricted Stock Unit
Kristen Harrington-Smith	SVP & CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2022	25,000	25,000 (0%)	0%		0	Common Stock
Kristen Harrington-Smith	SVP & CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2022	25,000	50,000	-		-	Restricted Stock Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2022	3,138	139,643	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2022	3,530	156,948	-		-	Deferred Share Unit
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2022	2,876	47,531	-		-	Deferred Share Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2022	3,333	136,505	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2022	3,750	153,418	-		-	Deferred Share Unit
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 3.82 per share.	30 Jun 2022	2,645	82,214 (0%)	0%	3.8	10,117	Common Stock
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 3.82 per share.	30 Jun 2022	3,342	436,208 (0%)	0%	3.8	12,783	Common Stock
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2022	3,055	44,655	-		-	Deferred Share Unit
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 3.82 per share.	30 Jun 2022	3,073	110,235 (0%)	0%	3.8	11,754	Common Stock
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 3.82 per share.	30 Jun 2022	3,342	7,168 (0%)	0%	3.8	12,783	Common Stock
Renee Lentini	V.P.-FIN., PRIN. ACCTG. OFF.	Grant, award, or other acquisition of securities at price $ 3.83 per share.	30 Jun 2022	2,509	18,297 (0%)	0%	3.8	9,597	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	133,172	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	149,668	-		-	Deferred Share Unit
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	105,458	-		-	Deferred Share Unit
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	102,326	-		-	Deferred Share Unit
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	74,954	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	63,000	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	44,000	44,000	-		-	Stock Option (right to buy)
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	32,066	32,066	-		-	Stock Option (right to buy)
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	10,932	40,932	-		-	Deferred Share Unit
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	8,712	41,600	-		-	Deferred Share Unit
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	25,556	25,556	-		-	Stock Option (right to buy)
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	83,363	83,363	-		-	Stock Option (Right to Buy)
Theresa Wingrove	SVP OF REGULATORY AFFAIRS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	166,725	250,088	-		-	Stock Option (Right to Buy)
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	787,500	1,181,250	-		-	Stock Option (Right to Buy)
Mark Joseph Enyedy	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	393,750	393,750	-		-	Stock Option (Right to Buy)
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	111,150	111,150	-		-	Stock Option (Right to Buy)
Anna Berkenblit	SVP & CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	222,300	333,450	-		-	Stock Option (Right to Buy)
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	60,000	90,000	-		-	Stock Option (Right to Buy)
Stacy Ann Coen	SVP & CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	30,000	30,000	-		-	Stock Option (Right to Buy)
Susan Altschuller	SVP AND CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	41,250	41,250	-		-	Stock Option (Right to Buy)
Susan Altschuller	SVP AND CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2022	82,500	123,750	-		-	Stock Option (Right to Buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2022	3,151	118,172	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2022	3,545	134,668	-		-	Deferred Share Unit
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2022	2,888	32,888	-		-	Deferred Share Unit
Theresa Wingrove	SVP, Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	204,930	204,930	-		-	Common Stock (right to buy)
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	1,100,000	1,100,000	-		-	Stock Option (right to buy)
Anna Berkenblit	SVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	311,700	311,700	-		-	Stock Option (right to buy)
Stacy Ann Coen	SVP & Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	333,465	333,465	-		-	Common Stock (right to buy)
Susan Altschuller	SVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	361,568	361,568	-		-	Common Stock (right to buy)
Renee Lentini	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2022	95,700	95,700	-		-	Common Stock (right to buy)
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Nov 2021	44,000	44,000	-		-	Stock Option (right to buy)
Tracey McCain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Nov 2021	30,000	30,000	-		-	Deferred Share Unit
Kristen Harrington-Smith	SVP & Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Nov 2021	450,000	450,000	-		-	Common Stock (right to buy)
Kristen Harrington-Smith	SVP & Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Nov 2021	75,000	75,000	-		-	Restricted Stock Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	2,380	113,202	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	2,380	129,304	-		-	Deferred Share Unit
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2021	44,000	44,000	-		-	Stock Option (right to buy)
Helen M. Thackray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Sep 2021	30,000	30,000	-		-	Deferred Share Unit
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share.	03 Sep 2021	10,000	25,000 (0%)	0%	4.6	46,400	Common Stock
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Sep 2021	50,000	0	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Sep 2021	18,000	0	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Sep 2021	10,000	0	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Sep 2021	5,000	0	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share.	03 Sep 2021	50,000	93,000 (0%)	0%	4.6	228,000	Common Stock
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share.	03 Sep 2021	18,000	43,000 (0%)	0%	2.1	37,800	Common Stock
Dean Jonathan Mitchell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.84 per share.	03 Sep 2021	5,000	15,000 (0%)	0%	1.8	9,200	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	2,048	110,822	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	2,048	126,924	-		-	Deferred Share Unit
Theresa Wingrove	SVP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	1,768	77,518 (0%)	0%	5.5	9,759	Common Stock
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	3,849	432,866 (0%)	0%	5.5	21,246	Common Stock
Anna Berkenblit	SVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	2,062	105,401 (0%)	0%	5.5	11,382	Common Stock
Thomas Ryll	SVP, Technical Operations	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	3,849	84,714 (0%)	0%	5.5	21,246	Common Stock
Stacy Ann Coen	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	2,330	2,330 (0%)	0%	5.5	12,862	Common Stock
Renee Lentini	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 5.52 per share.	30 Jun 2021	1,683	13,831 (0%)	0%	5.5	9,290	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	108,774	-		-	Deferred Share Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	124,876	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	90,458	-		-	Deferred Share Unit
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	87,326	-		-	Deferred Share Unit
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	59,954	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,000	48,000	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	44,000	44,000	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2021	1,666	93,774	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2021	1,666	109,876	-		-	Deferred Share Unit
Theresa Wingrove	SVP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	121,905	121,905	-		-	Common Stock (right to buy)
Mark Joseph Enyedy	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	05 Feb 2021	10,000	429,017 (0%)	0%		0	Common Stock
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	925,000	925,000	-		-	Stock Option (right to buy)
Anna Berkenblit	SVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	282,019	282,019	-		-	Common Stock (right to buy)
Stacy Ann Coen	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	185,016	185,016	-		-	Common Stock (right to buy)
Susan Altschuller	SVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	163,798	163,798	-		-	Common Stock (right to buy)
Renee Lentini	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2021	80,800	80,800	-		-	Common Stock (right to buy)
Renee Lentini	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jan 2021	40,400	40,400	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2020	3,750	90,015	-		-	Deferred Share Unit
Mark A. Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2020	3,750	106,117	-		-	Deferred Share Unit
Susan Altschuller	SVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jul 2020	300,000	300,000	-		-	Common Stock (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2020	2,934	86,265	-		-	Deferred Share Unit
Mark A. Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2020	2,934	102,367	-		-	Deferred Share Unit
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 3.91 per share.	30 Jun 2020	2,593	73,091 (0%)	0%	3.9	10,139	Common Stock
Mark J. Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 3.91 per share.	30 Jun 2020	5,241	439,017 (0%)	0%	3.9	20,492	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 3.91 per share.	30 Jun 2020	3,047	101,136 (0%)	0%	3.9	11,914	Common Stock
Thomas Ryll	VP, Technical Operations	Grant, award, or other acquisition of securities at price $ 3.91 per share.	30 Jun 2020	5,241	80,865 (0%)	0%	3.9	20,492	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 3.91 per share.	30 Jun 2020	342	21,724 (0%)	0%	3.9	1,337	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	83,331	-		-	Deferred Share Unit
Mark A. Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	99,433	-		-	Deferred Share Unit
Mark A. Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	75,458	-		-	Deferred Share Unit
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	72,326	-		-	Deferred Share Unit
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	44,954	-		-	Deferred Share Unit
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	17,000	33,000	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2020	50,000	50,000	-		-	Stock Option (right to buy)
Stacy Ann Coen	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2020	260,000	260,000	-		-	Common Stock (right to buy)
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Apr 2020	18,160	26,830 (0%)	0%		-	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Sale of securities on an exchange or to another person at price $ 3.43 per share.	01 Apr 2020	5,448	21,382 (0%)	0%	3.4	18,687	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Apr 2020	18,160	27,240	-		-	Restricted Share Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2020	3,958	66,331	-		-	Deferred Share Unit
Mark A. Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2020	3,958	82,433	-		-	Deferred Share Unit
Craig Barrows	Executive VP, General Counsel	Sale of securities on an exchange or to another person at price $ 4.99 per share.	24 Feb 2020	16,492	145,275 (0%)	0%	5.0	82,295	Common Stock
Theresa Wingrove	SVP of Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 4.99 per share.	24 Feb 2020	16,147	70,498 (0%)	0%	5.0	80,574	Common Stock
Mark J. Enyedy	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 4.99 per share.	24 Feb 2020	55,222	433,776 (0%)	0%	5.0	275,558	Common Stock
Anna Berkenblit	SVP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 4.99 per share.	24 Feb 2020	25,803	98,089 (0%)	0%	5.0	128,757	Common Stock
Thomas Ryll	SVP, Technical Operations	Sale of securities on an exchange or to another person at price $ 4.99 per share.	24 Feb 2020	16,790	75,624 (0%)	0%	5.0	83,782	Common Stock
Theresa Wingrove	SVP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2020	222,300	222,300	-		-	Stock Option (right to buy)
Mark J. Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2020	1,050,000	1,050,000	-		-	Stock Option (right to buy)
Anna Berkenblit	SVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2020	296,400	296,400	-		-	Stock Option (right to buy)
Thomas Ryll	SVP, Technical Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2020	222,300	222,300	-		-	Stock Option (right to buy)
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2020	76,760	76,760	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2019	2,641	62,373	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2019	2,641	78,475	-		-	Deferred Share Unit
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 1.99 per share.	31 Dec 2019	4,762	86,645 (0%)	0%	2.0	9,476	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 1.99 per share.	31 Dec 2019	662	8,670 (0%)	0%	2.0	1,317	Common Stock
Thomas Ryll	SVP, Technical Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Nov 2019	110,950	110,950	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2019	5,578	59,732	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2019	5,578	75,834	-		-	Deferred Share Unit
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2019	132,900	132,900	-		-	Stock Option (right to buy)
Craig Barrows	Executive VP, General Counsel	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	5,230	161,767 (0%)	0%	1.8	9,623	Common Stock
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	5,230	488,998 (0%)	0%	1.8	9,623	Common Stock
Blaine McKee	EVP & Chief Business Officer	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	5,230	5,230 (0%)	0%	1.8	9,623	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	5,230	123,892 (0%)	0%	1.8	9,623	Common Stock
Thomas Ryll	VP, Technical Operations	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	5,230	92,414 (0%)	0%	1.8	9,623	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 1.84 per share.	01 Jul 2019	3,536	8,008 (0%)	0%	1.8	6,506	Common Stock
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2019	6,221	54,154	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2019	6,221	70,256	-		-	Deferred Share Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	47,933	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	64,035	-		-	Deferred Share Unit
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	58,458	-		-	Deferred Share Unit
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	55,326	-		-	Deferred Share Unit
Richard J. Wallace	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Kristine Peterson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	27,954	-		-	Deferred Share Unit
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	18,000	18,000	-		-	Stock Option (right to buy)
Stuart A. Arbuckle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2019	4,000	16,000	-		-	Deferred Share Unit
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2019	45,400	45,400	-		-	Restricted Share Unit
Dean Jonathan Mitchell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2019	4,981	42,933	-		-	Deferred Share Unit
Mark Alan Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2019	4,981	60,035	-		-	Deferred Share Unit
Craig Barrows	Executive VP, General Counsel	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	14,870	156,537 (0%)	0%	5.6	83,272	Common Stock
Theresa Wingrove	VP of Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	11,032	81,883 (0%)	0%	5.6	61,779	Common Stock
Mark Joseph Enyedy	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	51,070	483,768 (0%)	0%	5.6	285,992	Common Stock
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	36,643	199,413 (0%)	0%	5.6	205,201	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	16,562	118,662 (0%)	0%	5.6	92,747	Common Stock
Thomas Ryll	VP, Technical Operations	Sale of securities on an exchange or to another person at price $ 5.60 per share.	22 Feb 2019	11,495	87,184 (0%)	0%	5.6	64,372	Common Stock
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Feb 2019	58,900	58,900	-		-	Stock Option (right to buy)
Craig Barrows	Vice-President,General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	231,750	231,750	-		-	Stock option (right to buy)
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	126,100	126,100	-		-	Stock Option (right to buy)
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	785,000	785,000	-		-	Stock Option (right to buy)
Richard J. Gregory	Executive VP & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	289,150	289,150	-		-	Stock option (right to buy)
Blaine McKee	EVP & Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	173,140	173,140	-		-	Stock Option (right to buy)
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	256,050	256,050	-		-	Stock Option (right to buy)
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	92,500	92,500	-		-	Stock Option (right to buy)
Thomas Ryll	VP, Technical Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	221,900	221,900	-		-	Stock Option (right to buy)
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2019	58,100	58,100	-		-	Stock Option (right to buy)
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 5.27 per share.	07 Jan 2019	3,038	236,056 (0%)	0%	5.3	16,014	Common Stock
Craig Barrows	Executive VP, General Counsel	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	2,455	171,407 (0%)	0%	4.1	10,016	Common Stock
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	2,244	92,915 (0%)	0%	4.1	9,156	Common Stock
Mark Joseph Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	2,455	534,838 (0%)	0%	4.1	10,016	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	2,455	135,224 (0%)	0%	4.1	10,016	Common Stock
Thomas Ryll	VP, Technical Operations	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	2,455	98,679 (0%)	0%	4.1	10,016	Common Stock
David G. Foster	V.P.-Fin., Prin. Acctg. Off.	Grant, award, or other acquisition of securities at price $ 4.08 per share.	03 Jan 2019	1,472	3,472 (0%)	0%	4.1	6,006	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	2,812	38,952	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2018	2,812	55,054	-		-	Deferred Share Unit
Mark A. Goldberg	None	Purchase of securities on an exchange or from another person at price $ 5.76 per share.	06 Nov 2018	30,000	53,800 (0%)	0%	5.8	172,800	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 8.00 per share.	16 Oct 2018	5,851	132,769 (0%)	0%	8	46,808	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2018	1,425	36,140	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2018	1,425	52,242	-		-	Deferred Share Unit
Anna Berkenblit	VP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 9.46 per share.	10 Sep 2018	5,851	138,620 (0%)	0%	9.5	55,350	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2018	1,387	34,715	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2018	1,227	50,817	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	33,328	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock option (right to buy)
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	49,590	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock option (right to buy)
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	54,458	-		-	Deferred Share Unit
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock Option (right to buy)
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock option (right to buy)
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	51,326	-		-	Deferred Share Unit
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	23,954	-		-	Deferred Share Unit
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock option (right to buy)
Stuart A. Arbuckle	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	4,000	10,500	-		-	Deferred Share Unit
Stuart A. Arbuckle	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	18,000	18,000	-		-	Stock option (right to buy)
Stuart A. Arbuckle	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	15,800	15,800	-		-	Stock option (right to buy)
Stuart A. Arbuckle	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2018	1,500	12,000	-		-	Deferred Share Unit
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Jun 2018	10,000	90,000	-		-	Stock option (right to buy)
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.05 per share.	06 Jun 2018	10,000	190,690 (0%)	0%	3.1	30,500	Common Stock
David Johnston	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 11.02 per share.	06 Jun 2018	10,000	180,690 (0%)	0%	11.0	110,200	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2018	1,283	29,328	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2018	1,118	45,590	-		-	Deferred Share Unit
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2018	25,000	113,518	-		-	Stock Option (right to buy)
Daniel M. Junius	None	Sale of securities on an exchange or to another person at price $ 12.02 per share.	16 Mar 2018	25,000	184,987 (0%)	0%	12.0	300,405	Common Stock
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.29 per share.	16 Mar 2018	25,000	209,987 (0%)	0%	4.3	107,250	Common Stock
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2018	10,000	100,000	-		-	Stock option (right to buy)
David Johnston	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 11.53 per share.	15 Mar 2018	10,000	180,690 (0%)	0%	11.5	115,300	Common Stock
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.05 per share.	15 Mar 2018	10,000	190,690 (0%)	0%	3.1	30,500	Common Stock
Craig Barrows	Executive VP, General Counsel	Sale of securities on an exchange or to another person at price $ 10.88 per share.	21 Feb 2018	15,498	168,952 (0%)	0%	10.9	168,618	Common Stock
Daniel M. Junius	None	Sale of securities on an exchange or to another person at price $ 12.00 per share.	21 Feb 2018	11,713	184,987 (0%)	0%	12	140,556	Common Stock
David Johnston	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 10.87 per share.	21 Feb 2018	21,060	180,690 (0%)	0%	10.9	228,922	Common Stock
Theresa Wingrove	VP of Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 10.88 per share.	21 Feb 2018	11,379	90,671 (0%)	0%	10.9	123,804	Common Stock
Mark J. Enyedy	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 10.87 per share.	21 Feb 2018	67,717	532,383 (0%)	0%	10.9	736,084	Common Stock
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 10.88 per share.	21 Feb 2018	34,486	239,094 (0%)	0%	10.9	375,208	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 10.88 per share.	21 Feb 2018	17,329	144,471 (0%)	0%	10.9	188,540	Common Stock
Thomas Ryll	VP, Technical Operations	Sale of securities on an exchange or to another person at price $ 10.88 per share.	21 Feb 2018	11,876	96,224 (0%)	0%	10.9	129,211	Common Stock
Daniel M. Junius	None	Sale of securities on an exchange or to another person at price $ 11.68 per share.	20 Feb 2018	25,000	196,700 (0%)	0%	11.7	292,000	Common Stock
Craig Barrows	Vice-President,General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	225,000	225,000	-		-	Stock option (right to buy)
David Johnston	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	256,500	256,500	-		-	Stock option (right to buy)
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	160,000	160,000	-		-	Stock option (right to buy)
Mark J. Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	1,100,000	1,100,000	-		-	Stock Option (right to buy)
Richard J. Gregory	Executive VP & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	256,500	256,500	-		-	Stock option (right to buy)
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	175,000	175,000	-		-	Stock Option (right to buy)
Thomas Ryll	VP, Technical Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2018	160,000	160,000	-		-	Stock Option (right to buy)
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share.	13 Feb 2018	46,667	243,367 (0%)	0%	3.3	154,001	Common Stock
Daniel M. Junius	None	Sale of securities on an exchange or to another person at price $ 10.01 per share.	13 Feb 2018	46,667	196,700 (0%)	0%	10.0	467,253	Common Stock
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.29 per share.	13 Feb 2018	25,000	221,700 (0%)	0%	4.3	107,250	Common Stock
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2018	25,000	163,518	-		-	Stock Option (right to buy)
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2018	46,667	0	-		-	Stock Option (right to buy)
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 6.64 per share.	08 Jan 2018	2,904	273,577 (0%)	0%	6.6	19,287	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	1,868	28,045	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	421	90,997	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	1,833	44,472	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2017	1,033	78,298	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2017	1,535	26,177	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2017	352	90,576	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2017	1,535	42,639	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2017	882	77,265	-		-	Deferred Share Unit
Craig Barrows	Executive VP, General Counsel	Sale of securities on an exchange or to another person at price $ 6.73 per share.	13 Sep 2017	22,450	184,450 (0%)	0%	6.7	151,053	Common Stock
Craig Barrows	Executive VP, General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share.	13 Sep 2017	30,000	206,900 (0%)	0%	4.5	135,000	Common Stock
Craig Barrows	Executive VP, General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share.	13 Sep 2017	20,000	191,500 (0%)	0%	4.5	90,000	Common Stock
Craig Barrows	Executive VP, General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2017	20,000	30,000	-		-	Stock Option (right to buy)
Craig Barrows	Executive VP, General Counsel	Sale of securities on an exchange or to another person at price $ 6.95 per share.	13 Sep 2017	14,600	176,900 (0%)	0%	6.9	101,404	Common Stock
Craig Barrows	Executive VP, General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2017	30,000	0	-		-	Stock Option (right to buy)
Anna Berkenblit	VP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.00 per share.	13 Sep 2017	1,500	161,800 (0%)	0%	7	10,500	Common Stock
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2017	1,652	24,642	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2017	379	90,224	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2017	1,652	41,104	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2017	949	76,383	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	22,990	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Daniel M. Junius	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	4,500	-		-	Deferred Share Unit
Daniel M. Junius	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock Option (right to buy)
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	89,845	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	39,452	-		-	Deferred Share Unit
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	50,458	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	75,434	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	47,326	-		-	Deferred Share Unit
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	10,000	10,000	-		-	Stock option (right to buy)
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2017	3,000	19,954	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2017	3,036	19,990	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2017	697	86,845	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2017	3,036	36,452	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2017	1,744	72,434	-		-	Deferred Share Unit
Peter J. Williams	VP, Business Development	Grant, award, or other acquisition of securities at price $ 2.57 per share.	23 Feb 2017	2,000	50,620 (0%)	0%	2.6	5,140	Common Stock
Anna Berkenblit	VP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 2.47 per share.	22 Feb 2017	157,300	163,300 (0%)	0%	2.5	388,531	Common Stock
Craig Barrows	Vice-President,General Counsel	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	140,400	171,500 (0%)	0%	2.5	346,788	Common Stock
Peter J. Williams	VP, Business Development	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	48,620	48,620 (0%)	0%	2.5	120,091	Common Stock
David Johnston	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	191,750	201,750 (0%)	0%	2.5	473,623	Common Stock
Theresa Wingrove	VP of Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	102,050	102,050 (0%)	0%	2.5	252,064	Common Stock
Mark J. Enyedy	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	500,000	600,100 (0%)	0%	2.5	1,235,000	Common Stock
Richard J. Gregory	Executive VP & CSO	Grant, award, or other acquisition of securities at price $ 2.47 per share.	21 Feb 2017	237,250	276,481 (0%)	0%	2.5	586,008	Common Stock
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 6.64 per share.	08 Jan 2017	2,904	273,577 (0%)	0%	6.6	19,287	Common Stock
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	1,985	86,148	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	5,759	33,416	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	6,617	70,690	-		-	Deferred Share Unit
Mark A. Goldberg	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Dec 2016	20,000	23,800	-		-	Common Stock
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	64,073	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock Option (right to buy)
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	47,458	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	84,163	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	16,954	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	27,657	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Daniel M. Junius	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock Option (right to buy)
Daniel M. Junius	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	1,500	-		-	Deferred Share Unit
Craig Barrows	Vice-President,General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	55,000	55,000	-		-	Stock option (right to buy)
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	44,326	-		-	Deferred Share Unit
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	1,500	16,954	-		-	Deferred Share Unit
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2016	5,000	5,000	-		-	Stock option (right to buy)
Mark J. Enyedy	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	08 Nov 2016	25,000	100,100	-		-	Common Stock
John M. Lambert	Executive Vice President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	02 Nov 2016	2,775	120,521	-		-	Common Stock
Craig Barrows	Vice-President,General Counsel	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	02 Nov 2016	10,000	31,100	-		-	Common Stock
David Johnston	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	02 Nov 2016	10,000	10,000	-		-	Common Stock
Richard J. Gregory	Executive VP & CSO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	02 Nov 2016	16,600	39,231	-		-	Common Stock
Sandra Poole	Executive VP, Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2016	27,500	27,500	-		-	Stock option (right to buy)
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2016	5,037	62,573	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2016	1,511	82,663	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2016	4,384	26,157	-		-	Deferred Share Unit
John M. Lambert	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	50,000	50,000	-		-	Stock option (right to buy)
Craig Barrows	Vice-President,General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	70,000	70,000	-		-	Stock option (right to buy)
Peter J. Williams	VP, Business Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	70,000	70,000	-		-	Stock option (right to buy)
David Johnston	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	110,000	110,000	-		-	Stock option (right to buy)
Charles Morris	Executive VP & CDO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	110,000	110,000	-		-	Stock option (right to buy)
Ellie Harrison	VP & Chief HR Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	70,000	70,000	-		-	Stock option (right to buy)
Sandra Poole	Senior VP, Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	110,000	110,000	-		-	Stock option (right to buy)
Richard J. Gregory	Executive VP & CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2016	110,000	110,000	-		-	Stock option (right to buy)
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2016	4,383	57,536	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2016	1,314	81,152	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2016	3,814	21,773	-		-	Deferred Share Unit
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2016	27,085	0	-		-	Stock Option (right to buy)
Daniel M. Junius	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2016	27,085	196,700	-		-	Common Stock
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2016	1,584	53,153	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2016	475	79,838	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2016	1,379	17,959	-		-	Deferred Share Unit
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2016	7,000	117,746	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2016	3,889	110,746	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2016	7,000	53,000	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2016	3,889	0	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2016	3,889	3,889	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2016	3,889	110,746	-		-	Common Stock
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Feb 2016	3,889	106,857	-		-	Common Stock
Richard J. Gregory	Executive VP & CSO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	08 Jan 2016	2,369	22,631	-		-	Common Stock
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	04 Jan 2016	3,889	106,857	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jan 2016	3,889	110,746	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jan 2016	3,889	7,778	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jan 2016	5,416	175,031	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	04 Jan 2016	5,416	169,615	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jan 2016	5,416	27,085	-		-	Stock Option (right to buy)
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2015	994	51,569	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Dec 2015	596	79,363	-		-	Deferred Share Unit
Daniel M. Junius	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	18 Dec 2015	1,003	169,615	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Dec 2015	3,889	11,667	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Dec 2015	3,889	106,857	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Dec 2015	3,889	110,746	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Dec 2015	5,416	170,618	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Dec 2015	5,416	176,035	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Dec 2015	5,416	32,501	-		-	Stock Option (right to buy)
Charles Morris	Executive VP & CDO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Nov 2015	5,170	27,090	-		-	Common Stock
Dean Jonathan Mitchell	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	17 Nov 2015	10,000	10,000	-		-	Common Stock
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	50,575	-		-	Deferred Share Unit
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	45,958	-		-	Deferred Share Unit
Stephen C. Mccluski	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	78,767	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Nicole Onetto	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	53,248	-		-	Deferred Share Unit
Nicole Onetto	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	15,454	-		-	Deferred Share Unit
Dean Jonathan Mitchell	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	16,580	-		-	Deferred Share Unit
Mark A. Goldberg	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	42,826	-		-	Deferred Share Unit
Richard J. Wallace	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	3,000	15,454	-		-	Deferred Share Unit
Kristine Peterson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Nov 2015	10,000	10,000	-		-	Stock option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Nov 2015	5,907	188,518	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Nov 2015	5,907	170,618	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Nov 2015	3,889	15,556	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Nov 2015	3,889	106,857	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Nov 2015	3,889	110,746	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	5,497	37,917	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	30 Oct 2015	5,497	159,812	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	5,575	159,690	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	122	62,669	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	5,497	165,309	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	5,575	194,425	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Oct 2015	122	159,812	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Oct 2015	5,335	159,450	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Oct 2015	5,335	154,115	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Oct 2015	5,335	43,414	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Oct 2015	3,889	110,746	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Oct 2015	3,889	19,445	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Oct 2015	3,889	106,857	-		-	Common Stock
Howard H. Pien	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2015	1,406	47,575	-		-	Deferred Share Unit
Joseph J. Villafranca	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2015	843	75,767	-		-	Deferred Share Unit
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Sep 2015	5,000	90,000	-		-	Stock Option (right to buy)
David Johnston	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Sep 2015	5,000	0	-		-	Common stock
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Sep 2015	5,000	5,000	-		-	Common stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Sep 2015	4,899	159,014	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Sep 2015	4,899	62,791	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Sep 2015	3,889	106,857	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2015	3,889	19,445	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2015	3,889	110,746	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Sep 2015	5,416	154,115	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2015	5,416	159,531	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2015	5,416	48,749	-		-	Stock Option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2015	12,310	154,115	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2015	12,310	67,690	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Aug 2015	3,889	106,857	-		-	Common Stock
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	3,889	27,223	-		-	Stock Option (right to buy)
John M. Lambert	Executive Vice President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	3,889	110,746	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Aug 2015	5,416	141,805	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	5,416	147,221	-		-	Common Stock
Daniel M. Junius	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	5,416	54,165	-		-	Stock Option (right to buy)
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	5,000	5,000	-		-	Common Stock
David Johnston	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2015	5,000	95,000	-		-	Stock Option (right to buy)
David Johnston	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Aug 2015	5,000	0	-		-	Common Stock
John M. Lambert	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2015	100,000	100,000	-		-	Stock option (right to buy)
Daniel M. Junius	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jul 2015	205,000	205,000	-		-	Stock option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for Immunogen, Inc.

The latest disclosure was made by Theresa Wingrove in Immunogen, Inc. where a trade of 187,667 Common Stock done at an average price of $29.6 was reported to US exchanges on Jan. 16, 2024.

Screeners based on Insider Trading and SAST parameters